Pricing Landed Exactly on Cue, But the Beat Landed Below the Operating Line
Key Takeaways
- The November 1 price increase did exactly what we were waiting to see: average net sales per case rose to $8.80 from $8.70, the first positive year-over-year print of 2025, and jumped 5.4% sequentially from $8.35. Net sales grew 17.6% against case volume of 16.9%, which is the "grow top line faster than units" commitment management made last quarter, delivered on schedule.
- The quality of the earnings beat is much weaker than the headline. Adjusted operating margin actually compressed 39bps to 29.0%; the entire 450bps of reported operating margin expansion is an artifact of comparing this quarter's $51.2M Alcohol Brands impairment against last year's $130.7M. A 21.0% effective tax rate and a $20.8M swing in interest income did the rest.
- GAAP EPS of $0.46 came in below the $0.48 to $0.49 consensus range while adjusted EPS of $0.51 came in above it. That split, not the growth rate, explains why the stock fell 1.6% on a quarter the wires called a beat.
- Management reversed last quarter's aluminum guidance. In November they expected the cost comparison to turn favourable; they now expect costs higher in Q1 and higher again in Q2 versus this quarter. Alcohol Brands took a second consecutive annual impairment and cost $73.0M in a quarter that generated $29.0M of segment revenue.
- Rating: Maintaining Hold. The operating thesis is working and every pricing commitment was met, but the shares rose 22.3% since our initiation while trailing adjusted earnings rose 6.7%, so roughly two-thirds of the move was multiple expansion to 41.4x. Fundamentals confirmed, risk/reward deteriorated.
Results vs. Consensus
Q4 2025 Scorecard
| Metric | Actual | Consensus | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Net sales | $2,131.1M | $2,040M | Beat | +4.5% |
| EPS (GAAP, diluted) | $0.46 | $0.48 to $0.49 | Miss | Below the range |
| EPS (adjusted, diluted) | $0.51 | $0.48 to $0.49 | Beat | Above the range |
| Gross margin | 55.5% | n/a | n/a | +20bps YoY |
| Operating income (adjusted) | $617.6M | n/a | n/a | +16.0% YoY |
| Case volume (192-oz equiv.) | 238.1M | n/a | n/a | +16.9% YoY |
| Average net sales per case | $8.80 | n/a | n/a | +1.1% YoY |
The EPS row is the one that matters, and it does not resolve cleanly in either direction. Published estimates for the quarter ranged from $0.48 to $0.49, and Monster delivered $0.46 on a reported basis and $0.51 adjusted. The reported figure missed every estimate in circulation; the adjusted figure cleared all of them. Coverage of the print led with the adjusted number and called it a beat. The tape disagreed, and the tape was reading the same disclosure everyone else was.
The gap between the two bases widened to $0.05 from $0.03 in the third quarter, because this quarter carries a $51.2M Alcohol Brands impairment on top of the segment's $21.7M operating loss. Investors who treat the adjusted figure as the real earnings power are excluding, for the second consecutive year, a write-down of a business the company still owns and still funds.
Year-Over-Year Comparisons
| Metric | Q4 2025 | Q4 2024 | Change |
|---|---|---|---|
| Net sales | $2,131.1M | $1,812.0M | +17.6% |
| Net sales, FX-neutral | n/a | n/a | +16.1% |
| Gross profit | $1,183.3M | $1,002.4M | +18.0% |
| Gross margin | 55.5% | 55.3% | +20bps |
| Operating expenses | $640.7M | $621.2M | +3.1% |
| Operating expenses, % of net sales | 30.1% | 34.3% | -420bps |
| Operating income (reported) | $542.6M | $381.2M | +42.3% |
| Operating margin (reported) | 25.5% | 21.0% | +450bps |
| Operating income (adjusted) | $617.6M | $532.2M | +16.0% |
| Operating margin (adjusted) | 29.0% | 29.4% | -39bps |
| Interest and other income, net | $25.7M | $4.9M | +$20.8M |
| Effective tax rate | 21.0% | 29.9% | -890bps |
| Net income | $449.2M | $270.7M | +65.9% |
| EPS (GAAP, diluted) | $0.46 | $0.28 | +64.9% |
| EPS (adjusted, diluted) | $0.51 | $0.39 | +30.4% |
| Case volume (000s, 192-oz equiv.) | 238,132 | 203,630 | +16.9% |
| Average net sales per case | $8.80 | $8.70 | +1.1% |
Two rows in that table tell opposite stories, and the reader should be clear which one is load-bearing. Reported operating margin expanded 450bps. Adjusted operating margin contracted 39bps. The difference is entirely the impairment comparison: $51.2M charged this year against $130.7M last year. On the basis management asks investors to use, this was a quarter of slight margin compression on 17.6% revenue growth.
Quarter-Over-Quarter Comparisons
| Metric | Q4 2025 | Q3 2025 | Change |
|---|---|---|---|
| Net sales | $2,131.1M | $2,197.1M | -3.0% |
| Gross profit | $1,183.3M | $1,224.5M | -3.4% |
| Gross margin | 55.5% | 55.7% | -20bps |
| Operating expenses | $640.7M | $549.1M | +16.7% |
| Operating income (reported) | $542.6M | $675.4M | -19.7% |
| Operating margin (reported) | 25.5% | 30.7% | -520bps |
| Effective tax rate | 21.0% | 23.9% | -290bps |
| Net income | $449.2M | $524.5M | -14.4% |
| EPS (GAAP, diluted) | $0.46 | $0.53 | -13.2% |
| Case volume (000s, 192-oz equiv.) | 238,132 | 258,387 | -7.8% |
| Average net sales per case | $8.80 | $8.35 | +5.4% |
Sequential declines are normal here: the fourth quarter is structurally Monster's weakest and the third its strongest, so the 3.0% revenue step-down and the 7.8% volume step-down are seasonal rather than diagnostic. The one row that is diagnostic is the last: average net sales per case rose 5.4% sequentially. That is the November pricing action arriving, and it is the cleanest possible confirmation that the lever we flagged as unquantified last quarter is real and roughly the size a normal price increase would be.
- Revenue: High quality and better composed than last quarter. Of the 17.6% reported growth, $27.7M of currency benefit accounts for roughly 150bps, leaving 16.1% FX-neutral, which is an acceleration from Q3's 15.1%. For the first time this year the growth is a genuine mix of volume and price rather than volume alone: cases up 16.9% and realised price per case up 1.1%.
- Margins: Low quality at the operating line. Gross margin rose only 20bps year over year, and adjusted operating margin fell 39bps. Operating expenses grew 16.7% sequentially against a 3.0% revenue decline. General and administrative expense excluding impairments ran 13.2% of sales against 12.1% a year ago, roughly 110bps of deleverage, which management disputed on the call but only by additionally excluding a $12.9M incentive-compensation true-up, $5.1M of professional services for the new AFF San Fernando facility, and $6.6M of digital transformation cost.
- EPS: Materially assisted from below the operating line. The effective tax rate of 21.0% is the lowest of the year against 23.9% in Q3 and a 23.2% full-year rate; had the quarter run at the full-year rate, EPS would have been approximately $0.44 rather than $0.46. Separately, interest and other income swung $20.8M higher year over year, worth roughly $0.02 per share after tax. Neither item is operational and neither is repeatable at this magnitude.
- Comparability: The adjusted prior-year base was restated. Monster changed its non-GAAP definition during 2025 to add back the Alcohol Brands operating loss separately, which lifted Q4 2024 adjusted EPS to $0.39 from the $0.38 originally published, and adjusted operating income to $532.2M from $517.9M. The "+30.4%" adjusted EPS growth is measured against the revised base.
Revenue assessment. This is the strongest top-line quarter of the year on the measure that matters, and the acceleration is real rather than optical. FX-neutral growth of 16.1% beats Q3's 15.1% despite lapping a fourth quarter of 2024 that was itself easier than the third. More importantly the composition changed. Every quarter of 2025 through September was pure volume with flat-to-down price; this quarter added a point of realised price on top of near-17% volume. That combination, if it holds, is what a durable mid-teens compounder looks like. January, at 16.7% FX-neutral against one fewer selling day, suggests it is holding.
Margin assessment. Gross margin of 55.5% is a fractional year-over-year gain and a 20bps sequential give-back, and it arrived alongside the encouraging detail that margin expanded year over year in all four geographic regions at once, including EMEA gaining 310bps to 35.8%. Both facts are true and they are reconciled by mix: the regions each improved while the consolidated blend shifted toward the lower-margin international business, which reached 42% of sales. Management's framing that they "don't bank gross profit percentages" but "bank gross profit dollars" is fair as far as it goes, and gross profit dollars did grow 18.0%. It is also the sort of framing companies adopt when the percentage has stopped expanding.
EPS assessment. The reported 64.9% EPS growth is close to meaningless as a measure of this quarter's operating performance, because the prior-year base was depressed by a $130.7M impairment and a 29.9% tax rate. The adjusted 30.4% is the better number, and even that flatters: it is measured against a restated base and it benefits from a 21.0% tax rate that is unlikely to repeat. Strip the tax and interest assistance and the underlying earnings growth is closer to the 16.0% adjusted operating income growth than to either headline. That is still a good result on 17.6% revenue growth. It is not a 65% one, and it is not a 30% one.
Segment Performance
| Segment | Q4 2025 | Q4 2024 | Growth | FX-Neutral | % of Net Sales |
|---|---|---|---|---|---|
| Monster Energy Drinks | $1.99B | $1.67B | +18.9% | +17.5% | ~93% |
| Strategic Brands | $110.0M | $102.0M | +7.8% | +4.7% | 5.2% |
| Alcohol Brands | $29.0M | $34.9M | -16.8% | n/a | 1.4% |
| Other | $5.9M | $5.1M | +15.1% | n/a | 0.3% |
| Total net sales | $2,131.1M | $1,812.0M | +17.6% | +16.1% | 100.0% |
Segment dollars are as disclosed by the company and are rounded; mix percentages are computed from them and may not sum to exactly 100.0%. The Total row is the income-statement figure, not a sum of the rounded segment lines.
Geographic Performance
| Region | Net Sales Growth | FX-Neutral Growth | Gross Margin | Prior-Year Gross Margin |
|---|---|---|---|---|
| United States & Canada | +13.3% | n/a | n/a | n/a |
| EMEA | +32.6% | +25.9% | 35.8% | 32.7% |
| Asia Pacific | +11.5% | +13.9% | 41.4% | 41.3% |
| Latin America & Caribbean | n/a | +15.1% | 45.1% | 42.7% |
| Total international | +26.9% | +23.1% | n/a | n/a |
International net sales of $903.3M represented approximately 42% of the total against 39% a year ago. Gross margin improved year over year in all four geographic regions, the second consecutive quarter of broad-based regional margin gains and the strongest single piece of evidence for the international pillar of our thesis.
Monster Energy Drinks
The core segment grew 18.9% to $1.99B, or 17.5% FX-neutral, and accelerated versus Q3's 17.7%. The composition of US growth is the more interesting disclosure. The Ultra family grew 24% in the quarter per Nielsen with flagship Ultra White up 32%, but management also called out that the full-sugar portfolio contributed more than a third of total US gains, growing 9.1% and accounting for the vast majority of full-sugar category growth. Juice Monster grew 37%.
"Based on Nielsen data, Monster's full sugar portfolio also delivered a meaningful contribution in this 2025 fourth quarter, representing more than 1/3 of the company's total U.S. gains and highlighting the depth of the portfolio." — Hilton Schlosberg, Vice Chairman and CEO
Assessment: A year of Monster commentary has framed zero-sugar as the growth engine and the margin driver, so a quarter in which full-sugar delivered a third of US gains is a useful corrective. It broadens the demand story beyond a single platform, which reduces the risk that Ultra's eventual deceleration takes the whole US business with it. It also complicates the gross margin story, since management has repeatedly attributed mix benefit to the shift away from full sugar.
Strategic Brands
Strategic Brands grew 7.8% to $110.0M, decelerating sharply from Q3's 15.9%, and only 4.7% FX-neutral against 13.2% in the prior quarter. Against that, management made the single most useful new disclosure of the call, sizing the affordable-energy business for the first time.
"The last count, our estimates for 2025 and I've never given this number before, but we'll give it now, were in the order of 100 million unit cases." — Hilton Schlosberg, Vice Chairman and CEO
Management named Nigeria, Egypt, Kenya, Mexico, India and China as the lead affordable markets, and noted that Predator and Fury combined are the number one energy drink brand by value in major African countries.
Assessment: Roughly 100 million unit cases is a meaningful figure set against total company volume of 959.0 million cases for the year: affordable energy is now on the order of a tenth of company volume while sitting inside a segment that is only 5.2% of net sales. That gap is the whole point of the affordable model, which sells concentrate at low revenue per case and high margin. The segment's reported deceleration to 4.7% FX-neutral matters less than it appears for the same reason. Investors should watch the case number management just volunteered, not the segment revenue line.
Alcohol Brands
Alcohol Brands fell 16.8% to $29.0M and took a $51.2M impairment charge, the second consecutive year in which the fourth quarter carries a write-down of this business. Adding the segment's $21.7M operating loss, Alcohol Brands cost $73.0M in a quarter in which it generated $29.0M of revenue. For the full year the segment cost $127.0M against roughly $134.7M of revenue.
Management's commentary was again confined to the product calendar: Blind Lemon continuing its national rollout, The Beast Perfect 10 shipping in the first quarter, and a national beer called Stunt Double plus a spirit-based ready-to-drink called Just Five planned for spring.
Assessment: Last quarter we called this the weakest disclosure in the release and flagged that a decision was overdue. A second consecutive annual impairment is that decision being deferred again, and the cost has now been quantified at close to the segment's entire annual revenue. Two write-downs in two years is not a valuation adjustment, it is a statement that the acquisition thesis has not worked. This escalates from a rounding error to a live capital-allocation question, and no analyst asked about it on either of the last two calls.
Key Operating Metrics
| KPI | Q4 2025 | Q3 2025 | Q4 2024 | YoY | Read |
|---|---|---|---|---|---|
| Average net sales per case | $8.80 | $8.35 | $8.70 | +1.1% | Turned positive; the quarter's headline result |
| Case volume (000s, 192-oz equiv.) | 238,132 | 258,387 | 203,630 | +16.9% | Held through the price increase |
| International share of net sales | ~42% | ~43% | ~39% | +3pts | Structurally higher, seasonally off the Q3 record |
| Gross margin | 55.5% | 55.7% | 55.3% | +20bps | Expanded in all four regions; blend diluted by mix |
| Adjusted operating margin | 29.0% | n/a | 29.4% | -39bps | The number the reported +450bps conceals |
| Stock-based compensation | $39.0M | $32.8M | $22.2M | +75.7% | $12.9M is an incentive-payout true-up |
| Effective tax rate | 21.0% | 23.9% | 29.9% | -890bps | Lowest of the year; not a run-rate |
| Diluted shares (000s) | 986,808 | 984,966 | 980,942 | +0.6% | Third consecutive quarter with no repurchases |
Assessment: The top two rows are the quarter. Monster raised price roughly a point and lost no volume, which is the outcome management predicted in November and the outcome we said we would grade them on. The bottom three rows are why the stock fell anyway: compensation expense accelerating faster than sales, an unrepeatable tax rate, and a share count that keeps drifting up while $500M of buyback authorisation sits unused for a third straight quarter.
Key Topics & Management Commentary
Overall Management Tone: Management was measurably more forthcoming than last quarter, volunteering the affordable-energy case number unprompted and giving a specific, sequenced view of aluminum cost pressure rather than deferring it. The confidence on demand was unqualified and well evidenced. Where the posture changed was on costs: the tone on aluminum moved from "we will lap this and benefit" in November to a quarter-by-quarter walk-through of increases through the first half, delivered without acknowledging that it reversed the prior guidance.
1. The Price Increase Worked, and Management Said So Plainly
The single question carried over from last quarter was whether the November 1 pricing action would deliver realised price without costing volume. It did. Average net sales per case rose to $8.80 from $8.70 year over year and from $8.35 sequentially, while case volume still grew 16.9%.
"we run our own playbook and we decide what's right for us and what's right for the company and what's right for our distributors and our consumers, and act accordingly. We also -- our GM plays a very big role in our pricing decisions, and you saw what happened with the price increase that we put into effect in November 1. And we're actually quite pleased with the way that went." — Hilton Schlosberg, Vice Chairman and CEO
In the prepared remarks management characterised the action as "targeted by channel and package analytics-driven" and reported "limited volume sensitivity."
Assessment: Commitment met in full. This resolves the largest open variable from our initiation and confirms the second pillar of the thesis. It also removes the main source of potential upside surprise: the pricing benefit is now in the base and visible to everyone, so from here it is an earnings contributor rather than an unpriced option. That distinction is why confirmation of the thesis does not, by itself, argue for an upgrade.
2. Aluminum Guidance Reversed From November
In November management said that once the 2025 increase in the Midwest premium anniversaried, the comparison would turn favourable. This quarter they laid out the opposite path for the first half.
"I think Q1 will probably be a little bit higher than what we saw in this quarter, and Q2 will be a little bit higher than that, and then we start overlapping and the rest of the year is overlapping on high aluminum prices in 2025. So I see some impact on in Q1, in Q2, but after that, it will just lap previous increases in aluminum." — Hilton Schlosberg, Vice Chairman and CEO
Management noted an active hedging program and said the in-quarter impact "was largely offset by the increase that we achieved in the increase in our selling price."
Assessment: This is the most important negative in the release and the most likely explanation for the share price reaction. The sequencing is now explicit and unfavourable: costs step up in Q1, step up again in Q2, and only lap from the second half. Note also what the offset admission means. If the November price increase was largely consumed offsetting aluminum, then the pricing benefit is not incremental to margin at all, it is defensive. That reframes the pricing win from a margin catalyst into a margin hedge.
3. Adjusted Operating Margin Compressed, Which the Headline Conceals
Reported operating margin expanded 450bps to 25.5%. On the adjusted basis management asks investors to use, operating margin fell to 29.0% from 29.4%. The entire reported expansion is the impairment comparison, $51.2M this year against $130.7M last.
The pressure came from operating expense rather than gross profit. Distribution rose to 4.2% of sales from 3.8% in the third quarter, selling to 10.3% from 9.8%, and general and administrative expense excluding impairments to 13.2% from 12.1% a year ago.
Assessment: A company growing net sales 17.6% and expanding gross profit dollars 18.0% should not be losing operating margin on an adjusted basis. The named causes are individually defensible and collectively a pattern: an incentive-compensation true-up, a new facility's start-up costs, and a multi-year ERP programme. The ERP in particular is a commitment through to a January 2028 go-live, so this is the first quarter of a cost line that will recur for two more years.
4. A Second Consecutive Annual Impairment of Alcohol Brands
The $51.2M impairment follows $130.7M in the fourth quarter of 2024. Segment revenue fell 16.8% to $29.0M, a fifth consecutive quarterly decline, while the segment's operating loss widened to $21.7M from $18.4M.
Assessment: Two write-downs in two consecutive years, with revenue still falling at a mid-teens rate and losses widening, is a failed acquisition being managed rather than resolved. The full-year cost of $127.0M against roughly $134.7M of segment revenue means Monster spent close to a dollar for every dollar of alcohol revenue it booked. Against $2.03B of adjusted net income this is affordable, which is precisely why it has been allowed to persist. Our bear pillar moves from contained to materialising.
5. Europe's Growth Is Two-Thirds Base, One-Third Innovation
EMEA grew 32.6% in dollars and 25.9% currency-neutral, with regional gross margin up 310bps to 35.8%, the largest regional margin gain in the quarter. Management provided an unusually specific decomposition of where that growth originates.
"In Europe, 2/3 of our growth is coming from the existing business, and 1/3 from innovation, where the rest of the category has been much more dependent on innovation. For example, the Ultra brand platform in the fourth quarter grew by 53% in Nielsen sales headlined by Ultra White, which grew at 59%." — Guy Carling, CEO, EMEA and OSP
Assessment: This directly answers the question we raised last quarter about whether the base was decaying behind a launch calendar. A two-thirds base contribution in the fastest-growing major region is the answer we wanted, and it is quantified rather than asserted. Combined with 310bps of regional margin expansion, EMEA is now doing the heaviest lifting in the entire equity story.
6. Lando Norris Scaled to 38 Markets and Recruited New Users
Monster Energy Lando Norris Zero Sugar expanded from 27 EMEA markets at the third quarter to 38 EMEA and OSP markets, helped by McLaren winning a second consecutive Constructors' Championship and Norris taking the Drivers' Championship. The full US rollout is on track for later in the first quarter of 2026.
"innovation, such as Lando Norris Zero Sugar grew usage with existing consumers, but also in itself, 25% of Lando sales were new to the category and 25% of Lando sales were new to consumers." — Guy Carling, CEO, EMEA and OSP
Assessment: A quarter of the product's sales recruiting genuinely new category users is a materially better outcome than the cannibalisation an athlete-branded line item usually produces. The championship timing is fortunate and not repeatable, which is the standing risk with borrowed brand equity. The US national rollout in the current quarter is the near-term test of whether it travels.
7. Asia Pacific Was Distorted by a Distributor System Failure
Asia Pacific grew only 11.5% in dollars, decelerating sharply from Q3's 28.7%, though currency-neutral growth of 13.9% exceeded the dollar figure. Management attributed roughly 6% to 7% of regional impact to a systems disruption at its Japanese distributor, with Japan down 15.2% and management stating sales would have risen approximately 4% to 5% without it. Operations returned to normal on February 1. South Korea fell 26.5% on bottler inventory movements while depletions grew.
Against those, China grew 78.9% and India 54.2% in dollars, with a January launch in Thailand exceeding expectations.
Assessment: The disclosure is specific, quantified and dated, which is the right way to handle a one-off. Two of the region's four large markets moving on distributor and bottler mechanics rather than consumption is a reminder that Monster's reported international revenue is a shipment number, not a demand number. The China and India rates are the signal in this region and both accelerated.
8. Mexico Decelerated Sharply on a Shipment-Depletion Gap
Mexico grew 11.7% in dollars and only 3.8% currency-neutral, against 26.8% and 30.1% respectively in the third quarter. Management attributed the gap to bottler inventory, noting depletions "far exceeded" shipments, and cited Nielsen data showing Monster up 20.3% and Predator up 28.9% for the three months to December.
Assessment: The sell-out data supports management's framing that consumption is intact. The timing still warrants attention. Mexico's excise tax on sugar and artificially sweetened drinks took effect in January 2026, and the quarter immediately preceding it saw bottlers reduce rather than build inventory, which is the opposite of what a pre-tax buy-forward would produce. Management did not mention the tax at any point on this call, having flagged it as a named 2026 risk in November.
9. The Digital Transformation Is a Multi-Year Cost Commitment
Management disclosed a comprehensive digital transformation initiative launched in 2025, including an upgrade to SAP S/4HANA with a planned go-live of January 1, 2028. The fourth quarter carried $6.6M of related expense in general and administrative costs, alongside $5.1M of professional services for the new AFF San Fernando facility.
Assessment: A 2028 go-live means eight more quarters of cost ahead, partly capitalised and partly expensed. For a company whose operating expense ratio is already the source of adjusted margin compression, this is a structural addition to the cost base rather than a one-time item, and it should be modelled as recurring through 2027.
10. Capital Allocation Unchanged and Still Unexplained
No shares were repurchased for a third consecutive quarter, leaving approximately $500.0M authorised as of February 25, 2026. Cash and investments closed the year at $3.25B across $2,088.1M of cash, $677.1M of short-term investments and $487.3M of longer-term investments, against zero long-term debt.
Assessment: Three consecutive quarters of repurchasing nothing, against $1.91B of full-year net income and a balance sheet that retired its remaining $374.0M of long-term debt during the year, is a deliberate choice that has gone unexplained and unquestioned. Cash and investments grew roughly $314M during the fourth quarter alone. The company that knows most about Monster's forward earnings has declined to buy the stock through a period in which it rose 22%.
11. Regional Leadership Restructured the Day Before the Print
Effective February 25, 2026, Rob Gehring moved from Chief Growth Officer to Chief Executive Officer, Americas; Guy Carling from President of EMEA and OSP to Chief Executive Officer, EMEA and OSP; and Emelie Tirre from Chief Commercial Officer to Chief Strategy Officer.
"We believe the leadership changes that we are announcing today will drive future performance and growth across the business." — Hilton Schlosberg, Vice Chairman and CEO
Assessment: The structure moves Monster from functional global roles to regional profit-and-loss ownership, which is the organisational shape a business with 42% international sales eventually needs. Gehring's move is the one to watch: he ran the November pricing action, and the executive most associated with revenue growth management now owns the Americas. The commercial and growth functions he and Tirre vacated were not visibly backfilled on the call.
Guidance & Outlook
Monster issues no formal revenue or earnings guidance, and management again declined to forecast when asked directly about 2026 category growth. The disclosed forward datapoints are collected below.
| Forward Datapoint | Disclosure | Status |
|---|---|---|
| January 2026 net sales | +20.5% reported; +21% reported ex-Alcohol | One fewer selling day than January 2025 |
| January 2026 net sales, FX-neutral | +16.7% | Accelerating vs. Q4's +16.1% |
| Aluminum costs | Higher in Q1 than Q4; higher again in Q2 | Reverses the November expectation of a favourable lap |
| Aluminum lapping | Comparison neutralises from H2 2026 | Management expects to "lap previous increases" |
| Further price increases | Under continuous review, domestic and international | No action announced |
| Innovation phasing | Staggered across H1, plus unannounced fall slate | Change from prior years' front-loading |
| Lando Norris US rollout | Full national rollout later in Q1 2026 | On track; already in 38 EMEA and OSP markets |
| The Beast Perfect 10 | Began shipping in Q1 2026 | Alcohol Brands |
| Stunt Double beer, Just Five RTD | Spring 2026 | Alcohol Brands |
| SAP S/4HANA go-live | January 1, 2028 | Recurring cost through 2027 |
| Share repurchase authorisation | ~$500.0M remaining as of February 25, 2026 | Unused for three consecutive quarters |
Implied Q1 ramp: January's 16.7% FX-neutral growth against one fewer selling day is the strongest month-to-date figure management has disclosed in our coverage period, and it sits above the fourth quarter's 16.1%. Applied to Q1 2025 net sales, a mid-teens rate implies first-quarter revenue somewhere near $2.1B. The offsetting pressure is explicit: aluminum steps up in the first quarter and again in the second, so revenue acceleration and gross margin pressure are likely to arrive together.
Street at: With no company guide, consensus is unanchored and the January datapoint carries disproportionate weight in near-term estimate revisions. Note that January 2026 laps a January 2025 that preceded the Nov 1 pricing, so roughly a point of the growth is price that was not in the year-ago base.
Guidance style: Unchanged and still the most conservative in large-cap staples. The notable shift this quarter is that management volunteered a specific, sequenced cost outlook for the first half without being pressed for it, which is a departure from the November posture of deferring quantification. Companies generally get specific about costs when they expect the market to notice.
Analyst Q&A Highlights
What Is Driving the Acceleration in International Share Gains
The opening question asked what changed to accelerate international share gains and how durable it is, paired with a request for detail on the affordable-energy strategy in emerging markets. The answer produced the call's most valuable new disclosure, a first-ever sizing of the affordable business, before handing the share question to the newly appointed regional chief executive.
Q: "But just was more focused on what you think has driven the recent acceleration and how sustainable that is? And then also within that, maybe you can touch on the affordable energy strategy and how that's performing in emerging markets in terms of incrementality for the category and driving category development?"
— Dara Mohsenian, Morgan Stanley
A: "So if you look at the affordable energy category, it's a way of positioning energy drinks to markets where the affordability of Monster is somewhat out of reach. And we've always wanted to establish Monster as our lead brand, that is at a particular price point. And we've never wanted to take that down to where the affordable category should be."
— Hilton Schlosberg, Vice Chairman and CEO
Assessment: The strategic logic is sound and the volume disclosure that followed is the kind of number that should have been given a year ago. Positioning affordable brands as a separate price tier protects Monster's own price architecture, which is exactly the discipline that made the November increase possible. The answer also quietly explains why Strategic Brands revenue growth understates the strategy's progress: concentrate economics book far less revenue per case than the finished-goods model.
Whether US Category Growth and Shelf Space Can Continue Expanding in 2026
A question on the durability of US category growth into 2026, including whether the category should keep winning distribution space, drew the customary refusal to guide followed by a structural argument. Management extended it further than usual by naming where incremental space would come from.
Q: "I'd love to get your perspective on the U.S. energy drink category for 2026. Obviously, phenomenal growth in 2025, coming off a relatively easier base in '24. But clearly, the momentum is continuing. As you mentioned, there's some long-term drivers. And in terms of distribution gains, do you expect the category to continue to gain distribution space in 2026?"
— Filippo Falorni, Citi
A: "And there's also an opportunity to gain space from alcohol, which is underperforming and other products in the beverage category, which are also underperforming. And what we've always said, and I sort of want to stress that space for innovation, we always see that as incremental. We never want to take from our existing space for our innovation SKUs."
— Hilton Schlosberg, Vice Chairman and CEO
Assessment: Naming alcohol as the shelf space Monster expects to take is a pointed thing to say in a quarter that included a second consecutive impairment of Monster's own alcohol business. The strategic read is coherent, that energy is winning share of the total beverage cooler, and it is a better long-run argument than category growth rates. The discipline of never trading existing space for innovation space is the operationally important half of the answer and is what makes the innovation calendar genuinely incremental.
Margin Progression and Whether the G&A Investment Items Recur
The sharpest question of the call noted the apparent contradiction between regional gross margin expansion and the called-out tariff and inflation pressure, then pressed on general and administrative deleverage and whether the named investment items are ongoing or one-time. Management addressed cost sequencing at length and rejected the deleverage framing.
Q: "And also on G&A, that's one area where you saw some deleverage despite the top -- the strong top line performance. You listed a couple of specific items in the prepared remarks, but can you provide a little more detail on G&A and the progress from here? Are some of the investment areas ongoing or more onetime in nature?"
— Matthew Smith, Stifel
A: "So if you adjust and you take those numbers into consideration and you adjust the G&A numbers that are in our release and in the script and you'll see in the K, you'll see that we -- the leverage is actually the percentage of G&A as a percentage of sales is actually coming down rather than going up as you possibly suggested."
— Hilton Schlosberg, Vice Chairman and CEO
Assessment: The rebuttal is arithmetically defensible and analytically thin. Excluding impairments alone, general and administrative expense ran 13.2% of sales against 12.1% a year earlier, which is deleverage. It only becomes leverage after additionally removing the incentive true-up, the new facility's professional services and the digital transformation cost. Two of those three recur: the ERP programme runs to a 2028 go-live and the facility is now operating. Answering a deleverage question by proposing three more adjustments is the least convincing moment of the call.
Whether Further Pricing Is Coming, and How Innovation Is Phased
A follow-up asked whether additional pricing would be taken to offset cost pressure, and separately how the 2026 innovation calendar is weighted. The pricing half drew the clearest retrospective endorsement of the November action management has given.
Q: "Would you consider further pricing actions to offset the cost pressures? And then I did have a couple of questions on innovation. First, maybe Hilton, can you give us a sense of the phasing of your innovation this year? Is it more first half versus second half weighted? Or is it more balanced throughout the year?"
— Bonnie Herzog, Goldman Sachs
A: "And I also said on the script -- in the script that it really went according to plan. And we didn't really see a fall in volumes. And now turning to your question on innovation. This year, we will be seeing innovation staggered across at least the first half of the year for the ones that have already been announced."
— Hilton Schlosberg, Vice Chairman and CEO
Assessment: "We didn't really see a fall in volumes" is management grading its own November commitment, and the case data supports the claim. On further pricing, the answer is a maintained option rather than a plan, which is the right posture given aluminum costs rise for two more quarters. The shift to staggered innovation from prior years' front-loading is a real operational change: it smooths the quarterly revenue contribution from launches and makes any single quarter's innovation slate less decisive.
The New Indian Bottler and How the Relationship Is Governed
A question sought detail on India, where Monster has a new bottling partner, and on how governing principles and long-range vision get aligned at the outset of a major new bottler relationship. The answer covered enthusiasm and competitive positioning but not governance.
Q: "Hilton, can you please share with us perhaps some more detail on how it's going in India? You have a new bottler there. Can you also please shed some light on how you get the governing principles and the long-range vision rate with such an important new bottler when you have a new bottling relationship, please?"
— Carlos Alberto Laboy, HSBC
A: "I know that and have met the Chief Executive on a number of occasions, and they are very, very excited with the opportunity for Monster and Predator in India and for the ability to compete effectively with famous competition that is in the blue can."
— Hilton Schlosberg, Vice Chairman and CEO
Assessment: India grew 54.2% in dollars and 62.3% currency-neutral, so the enthusiasm is earned. The governance half of the question went unanswered, which matters more than it might appear: Monster's international economics are determined by bottler agreements, and India is being built on a new one at the same time the affordable-brand strategy is being scaled there. The answer describes a relationship, not a structure.
How to Model Margin Against Hedges, Mix and Affordable Brands
The final exchange asked how to think about margin going forward given the aluminum hedges, the international expansion and the affordable-energy mix effect. Management restated the first-half cost pressure and pointed to the regional evidence rather than offering a consolidated framework.
Q: "I know you don't bank margins and you bank dollars. But just wondering how we should be thinking given the hedges and what has been happening with the aluminum prices? And obviously, you had an expansion and which is remarkable, but just thinking of ahead, how we should be embedding the international expansion, the low price energy mix, geography effects, would be very helpful."
— Andrea Teixeira, JPMorgan
A: "So we do see some pressure in the first and second quarter of 2026. And so I'm not sure what else to what else to add to that. Internationally, you've seen what's happened with our gross margins. We've been able to increase margin in each of the territories that we have -- that we participated and reported on."
— Hilton Schlosberg, Vice Chairman and CEO
Assessment: The question asked for a framework and got a data recitation. "I'm not sure what else to add" is a genuine limit rather than a dodge, but it leaves the central modelling problem unresolved: consolidated gross margin is the net of four regions all improving and a mix shifting toward the lowest-margin of them, offset by a known aluminum step-up. Management has confirmed each input separately and declined to net them. That is why our own gross margin assumption stays a range rather than a point.
What They're NOT Saying
- That the aluminum guidance changed. In November management expected to benefit as the Midwest premium lapped. This quarter they walked through increases in Q1 and again in Q2. The reversal was delivered as fresh information rather than as a correction, and no analyst noted the change.
- Any mention of FLRT. In November management committed to launching FLRT, a new female-focused brand, in four flavours late in the first quarter of 2026. It was not mentioned once on this call, in a section of prepared remarks that otherwise walked through the innovation calendar in detail.
- Any mention of Storm Energy. Also committed in November, for a second-quarter 2026 launch in the wellness zero-sugar segment. Absent from this call entirely.
- The Mexico excise tax. Flagged by management in November as a named 2026 risk, effective January 2026, it went unmentioned even as Mexico decelerated to 3.8% currency-neutral growth from 30.1% and management explained the gap purely through bottler inventory.
- Anything from the December Investor Day. The event management twice deferred questions to in November was not referenced on this call, and no long-term targets or capital-allocation framework were discussed.
- Why the buyback remains dormant. Three consecutive quarters, zero repurchases, $500.0M authorised, $3.25B of cash and investments, no debt, and no question asked for the second consecutive quarter.
- What the Alcohol Brands endgame is. A second annual impairment, a fifth consecutive revenue decline and a widening operating loss produced only a product calendar. Management named alcohol as a category it expects to take shelf space from, without addressing owning one.
- Who now runs commercial and growth. Two functional roles were vacated in the reorganisation and no successors were named.
Market Reaction
- Pre-print setup: MNST closed at $86.66 on February 26, its highest close of the trailing 52 weeks, up 13.0% year to date against the S&P 500's 0.9% and up 67.8% over twelve months. The stock had gained 6.4% over the prior thirty days, entering the print at the top of a 52-week closing range of $51.65 to $86.66.
- Reaction session: Shares opened at $85.75, a 1.1% gap down, traded between $84.69 and $87.38, and closed at $85.30 for a loss of 1.6%, or $1.36.
- Volume: 13.6M shares against a 30-day average of 6.5M, a 2.1x multiple.
- Relative performance: The S&P 500 fell 0.4% on the session, so roughly 1.2 points of the decline was stock-specific.
A 1.6% decline on a quarter with 17.6% revenue growth and a 4.5% revenue beat requires explanation, and the price action itself supplies part of it. The stock gapped down at the open rather than fading intraday, which means the selling reflected the disclosure rather than a change of mind during the session. Three things in that disclosure would do it: GAAP EPS below every published estimate, adjusted operating margin compressing, and an explicit two-quarter path of rising aluminum costs that contradicted what management said in November.
The setup mattered as much as the print. Entering at the highest close of the year after a 67.8% twelve-month advance leaves no cushion for a quarter whose earnings quality is weaker than its headline. Investors who had underwritten the November pricing action as incremental margin heard management call the quarter's cost impact modest and "largely offset" by that price increase, which recasts the pricing as a hedge rather than a catalyst. The 2.1x volume indicates that repositioning, not drift, and the failure to hold the prior close on that volume is consistent with a stock priced for the good news it received.
Street Perspective
Debate: Is the Pricing Win Incremental Margin or Just a Cost Offset?
Bull view: Realised price per case turned positive with no volume loss, proving the pricing architecture works. Aluminum pressure laps from the second half, at which point the pricing benefit flows through unopposed and margin expands materially.
Bear view: Management said the in-quarter cost impact was "largely offset" by the price increase, meaning the pricing did not add margin, it defended it. With costs rising in Q1 and again in Q2, the offset is consumed before it ever reaches the bottom line, which is exactly what adjusted operating margin compressing 39bps demonstrates.
Our take: The bear reading is correct through the first half and the bull reading is probably correct after it. That timing is the whole argument, and it means the earnings benefit investors expected in 2026 arrives in the second half rather than the first. At 41.4x trailing adjusted earnings, waiting two quarters is not free.
Debate: Does Adjusted Operating Margin Compression Signal a Structural Cost Problem?
Bull view: The compression is explained by three identifiable items, an incentive-compensation true-up, a new facility's start-up costs and the first quarter of an ERP programme. Strip them and the cost ratio improves, exactly as management argued.
Bear view: Two of the three recur, the ERP through a 2028 go-live. A company that needs three exclusions to demonstrate leverage on 17.6% revenue growth does not have leverage, and distribution and selling expense ratios both rose sequentially as well.
Our take: Closer to the bear. The individual items are real and the pattern is the point: this is the second consecutive quarter in which operating expense grew faster than the underlying business once impairments are set aside. It does not break the thesis, but it caps how much of the top-line growth reaches earnings.
Debate: Has the Multiple Outrun the Fundamentals?
Bull view: A business compounding revenue in the high teens with international at 42% of sales, pricing power just demonstrated, and no debt deserves a premium multiple. January accelerating to 16.7% currency-neutral says the compounding continues.
Bear view: The stock rose 22.3% since early November while trailing adjusted earnings rose 6.7%. Roughly two-thirds of the move was re-rating, taking the trailing adjusted multiple from 36.1x to 41.4x. The fundamental news in that window, while good, was not a 15% re-rating's worth.
Our take: The bear has the arithmetic. The business earned an upgrade to its narrative this quarter and the market has already paid for one, plus a margin of anticipation. This is the same conclusion we reached in November at $69.73, and it is more true at $85.30.
Model Update & Valuation Framework
| Driver | Prior Assumption (Nov 2025) | Revised Assumption | Reason |
|---|---|---|---|
| Net sales growth (FX-neutral) | +12% to +13% | +14% to +16% | Q4 at +16.1% and January at +16.7% both beat our assumption |
| Case volume growth | +11% to +13% | +13% to +15% | Pricing cost no volume; +16.9% in Q4 vs. our low-teens estimate |
| Average net sales per case | +1% to +3% from Q1 2026 | +1% to +2% | Delivered early at +1.1% in Q4; November action now in the base |
| Gross margin | 55.0% to 56.0% | 54.5% to 55.5% | Aluminum steps up in Q1 and again in Q2; mix dilution continues |
| Operating expenses, % of sales | 25.0% to 26.0% | 26.0% to 27.0% | ERP cost recurs to 2028; two consecutive quarters of opex outgrowing sales |
| Effective tax rate | 24.0% to 25.0% | 23.0% to 24.5% | FY2025 came in at 23.2%; Q4's 21.0% is not a run-rate |
| Diluted shares | ~985M | ~988M | Buyback dormant three quarters; count drifting up on dilution |
| Alcohol Brands | Continued decline, loss persists | Decline plus recurring impairment risk | Second consecutive annual write-down; FY2025 cost $127.0M |
Valuation
| Metric | Value | Note |
|---|---|---|
| Share price (Feb 27 close) | $85.30 | Reaction-session close |
| Shares outstanding | 978.1M | As of December 31, 2025 |
| Market capitalisation | ~$83.4B | Derived from the two rows above |
| Cash and investments | $3.25B | $2,088.1M cash + $677.1M short-term + $487.3M investments |
| Long-term debt | $0.0M | Unchanged from September 30, 2025 |
| Enterprise value | ~$80.2B | Market cap less net cash |
| FY2025 net sales | $8,294.3M | +10.7% YoY |
| FY2025 EPS (GAAP, diluted) | $1.94 | +29.9% YoY |
| FY2025 EPS (adjusted, diluted) | $2.06 | +24.5% YoY |
| P/E, trailing GAAP | ~44.0x | |
| P/E, trailing adjusted | ~41.4x | Was ~36.1x at our initiation |
| EV / trailing net sales | ~9.7x | Was ~8.2x at our initiation |
The re-rating is the story. Since our November initiation the shares rose 22.3%, from $69.73 to $85.30. Trailing adjusted earnings per share rose 6.7%, from $1.93 to $2.06. The trailing adjusted multiple therefore expanded 14.7%, from 36.1x to 41.4x, which accounts for roughly two-thirds of the total return. The quarter's news was good; it was not a 15% re-rating's worth of good, particularly with adjusted operating margin compressing and a two-quarter cost headwind newly disclosed.
Fair value framework. We estimate FY2026 adjusted diluted EPS of approximately $2.30, roughly 12% growth on FY2025's $2.06. That embeds mid-teens currency-neutral revenue growth consistent with the January datapoint, gross margin in a 54.5% to 55.5% range reflecting the disclosed first-half aluminum step-up, continued modest operating expense deleverage from the ERP programme, and a normalised 23% to 24.5% tax rate rather than the fourth quarter's 21.0%. Applying 33x to 36x produces a fair value range of $75.90 to $82.80, with a midpoint of $79.35. Against the $85.30 close that implies approximately -7.0%. That is a modestly negative expected return rather than a broken thesis, which is why this stays a Hold and not yet a downgrade: none of the triggers below has fired, but the multiple is now doing work the earnings are not.
What would change the rating. Upgrade triggers: gross margin holding above 55% through the first-half aluminum step-up, a capital-allocation decision that puts the $3.25B and the idle authorisation to work, or a share-price pullback toward the low $70s that restores a double-digit expected return. Downgrade triggers: a third consecutive quarter of adjusted operating margin compression, a further Alcohol Brands impairment without a stated exit, or the shares advancing again without earnings following, which would take the multiple past the mid-40s on trailing adjusted earnings.
Thesis Scorecard Post-Earnings
The pillars below are the same six established at initiation in November, graded against what this quarter revealed.
| Thesis Point | Status | Notes |
|---|---|---|
| Bull 1: International inflection is real and margin-accretive | Confirmed | 42% of sales; +26.9% growth (+23.1% FX-neutral); gross margin expanded YoY in all four geographic regions, EMEA +310bps to 35.8%. Second consecutive quarter of broad regional margin gains |
| Bull 2: Volume-led growth with pricing optionality untouched | Confirmed, now realised | Average net sales per case $8.80 vs. $8.70, +1.1% YoY and +5.4% QoQ, with case volume still +16.9%. The optionality has been exercised, so this pillar converts from a future lever to a delivered one |
| Bull 3: Gross margin structurally reset near 55.7% | Challenged | 55.5%, down 20bps sequentially. Regional expansion is real but consolidated blend is diluted by mix, and management guided to aluminum increases in Q1 and again in Q2, reversing November's expectation of a favourable lap |
| Bear 1: Valuation leaves no margin for error | Confirmed, escalating | Multiple expanded from 36.1x to 41.4x trailing adjusted while the stock rose 22.3% on 6.7% earnings growth. Printed at the 52-week high and fell 1.6% on a headline beat |
| Bear 2: Alcohol Brands is an unaddressed drag | Escalating | Second consecutive annual impairment ($51.2M after $130.7M); fifth consecutive revenue decline; operating loss widened to $21.7M. FY2025 total cost $127.0M against roughly $134.7M of segment revenue |
| Bear 3: Rising tax rate and widening regulatory surface | Challenged | The tax leg reversed: ETR fell to 21.0% in the quarter and 23.2% for the year, below FY2024's 24.1%. Mexico's excise tax took effect in January and went unmentioned. Aluminum replaced tax as the live cost risk |
Overall: Thesis substantially intact with the composition shifting. The two pillars that carried the initiation, international and pricing, both delivered, and Bull 2 has now converted from an unpriced option into a realised result. Working against that, the gross margin pillar is challenged for the first time, Alcohol Brands has escalated from a rounding error to a live capital-allocation failure, and the valuation bear point has strengthened materially. The business is performing better than we assumed in November; the stock has more than kept pace.
Action: Maintain Hold. Do not add at $85.30. The first half of 2026 carries a disclosed and unhedged-in-full cost step-up against a multiple that already discounts the second-half recovery. We would revisit constructively toward the low $70s, or on evidence that gross margin is holding above 55% while aluminum is still rising, which would be the strongest possible refutation of our margin concern.